Seattle Genetics to Acquire Cascadian Therapeutics

Edward Kim | |

SGEN adds CASC's late stage breast cancer therapeutic pipeline.

Biocept (BIOC): bringing a Cost-Efficient and more Accurate Liquid Biopsy to the Market

Stephen L Kanaval | |

Biocept Inc. (BIOC) has patented molecular diagnostic technology that uses an antibody to detect circulating tumor cells (CTCs)

Biocept at the Forefront of Liquid Biopsy

Stephen L Kanaval | |

Many tissue biopsies for lung cancer don’t give doctors the answers they need. Biocept's liquid biopsy technology could change all of that.

12 IPOs Planned for February 3 Week

Francis Gaskins | |

The full IPO calendar is available at Ranked by size of IPO, largest first. (1) Real estate finance Based in New York, NY, Ladder Capital ($LADR) scheduled a $225 million IPO on the

IPO Report: Biocept (BIOC)

Francis Gaskins | |

Biocept (BIOC) is an early-stage cancer diagnostics company that develops and commercializes proprietary circulating tumor cell, or CTC, and circulating tumor DNA, or ctDNA, tests utilizing a

Stocks Under $10: Medical Products & Services

Richard Suttmeier | |

At we show that the Medical sector is 9.8% overvalued. The Medical Products industry is 4.2% overvalued. The Medical Services industry is 9.1% overvalued. The Medical


Symbol Last Price Change % Change






Blockchain in Mobility - Discussion at the EU Parliament

From the recent Blockchain For Europe Summit in Brussels: Panel on Mobility and Transportation